Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection

WOBURN, Mass. May 6, 2024 – Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products...

US FDA Approves High-Concentration, Citrate-Free Formulation of Cyltezo (adalimumab-adbm) injection

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the high-concentration, citrate-free formulation of...

Dogs Brought to U.S. Must Be Microchipped, Older Than 6 Months: CDC

Dogs brought into the United States from abroad must be compliant with new rules to help fight rabies in this country, according to updated guidance from...

MRE-Liver Stiffness Measure Better for Varices in NAFLD Cirrhosis

For patients with obesity and nonalcoholic fatty liver disease (NAFLD) compensated cirrhosis (CC), liver stiffness measurement (LSM) by magnetic resonance...

Maltreatment as a Child Ups Odds of Substance Use Admissions by Age 40 Years

People with a history of child maltreatment (CM) appear to have significantly higher odds of inpatient admissions for alcohol use disorders (AUDs) and...

More Than 321,000 U.S. Kids Lost a Parent to Drug ODs in a Decade

More than 320,000 U.S. children lost a parent to drug overdose during the past decade, according to a new study reported May 8 in JAMA Psychiatry. What’s...

Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk

Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a...

Trifarotene Plus Skin Care Beneficial for Acne Vulgaris

Trifarotene plus skin care is beneficial for patients with moderate acne vulgaris (AV) and acne-induced hyperpigmentation (AIH), according to a study published...

About 90% of U.S. Adults Are On the Way to Heart Disease

Nine of 10 American adults are in the early, middle or late stages of a syndrome that leads to heart disease, a new report finds, and almost 10% have the...

There's a New Set of COVID Variants Called FLiRT: What You Need to Know

The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has reported. The...

Positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

STOCKHOLM, May 6, 2024. Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its...

Phase 2 data for Erleada plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localized prostate cancer results published

SAN ANTONIO, May 3, 2024. Johnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment...

An Orangutan Healed Himself With Medicinal Plant

Primates are capable of tending to wounds using medicinal plants, a new case report says. A male Sumatran orangutan treated a facial wound with a climbing...

Read more news...

Recently Added

Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
  • Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
  • Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist indicated in patients 12 years of age and older with WHIM syndrome...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development